SEARCH
= Paid-up subscribersRanolazine effective for angina in diabetes patients with high CVD risk. Practitioner 2013; 257 (1760): 10
Ranolazine effective for angina in diabetes patients with high CVD risk
25 Apr 2013
Ranolazine, a sodium channel blocker, significantly improved angina in patients with diabetes and coronary artery disease (CAD), a randomised, double-blind trial has found.
This article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.